Blood-based protein mediators of senility with replications across biofluids and cohorts.

aging cognition dementia g intelligence

Journal

Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125

Informations de publication

Date de publication:
2020
Historique:
received: 05 08 2019
revised: 25 09 2019
accepted: 07 10 2019
entrez: 21 9 2020
pubmed: 22 9 2020
medline: 22 9 2020
Statut: epublish

Résumé

Dementia severity can be quantitatively described by the latent dementia phenotype 'δ' and its various composite 'homologues'. We have explored δ's blood-based protein biomarkers in the Texas Alzheimer's Research and Care Consortium. However, it would be convenient to replicate them in the Alzheimer's Disease Neuroimaging Initiative. To that end, we have engineered a δ homologue from the observed cognitive performance measures common to both projects [i.e. 'd:Texas Alzheimer's Research and Care Consortium to Alzheimer's Disease Neuroimaging Initiative' (dT2A)]. In this analysis, we confirm 13/22 serum proteins as partial mediators of age's effect on dementia severity as measured by dT2A in the Texas Alzheimer's Research and Care Consortium and then replicate 4/13 in the Alzheimer's Disease Neuroimaging Initiative's plasma data. The replicated mediators of age-specific effects on dementia severity are adiponectin, follicle-stimulating hormone, pancreatic polypeptide and resistin. In their aggregate, the 13 confirmed age-specific mediators suggest that 'cognitive frailty' pays a role in dementia severity as measured by δ. We provide both discriminant and concordant support for that hypothesis. Weight, calculated low-density lipoprotein and body mass index are partial mediators of age's effect in the Texas Alzheimer's Research and Care Consortium. Biomarkers related to other disease processes (e.g. cerebrospinal fluid Alzheimer's disease-specific biomarkers in the Alzheimer's Disease Neuroimaging Initiative) are not. It now appears that dementia severity is the sum of multiple independent processes impacting δ. Each may have a unique set of mediating biomarkers. Age's unique effect appears to be at least partially mediated through proteins related to frailty. Age-specific mediation effects can be replicated across cohorts and biofluids. These proteins may offer targets for the remediation of age-specific cognitive decline (aka 'senility'), help distinguish it from other determinants of dementia severity and/or provide clues to the biology of Aging Proper.

Identifiants

pubmed: 32954311
doi: 10.1093/braincomms/fcz036
pii: fcz036
pmc: PMC7425523
doi:

Types de publication

Journal Article

Langues

eng

Pagination

fcz036

Subventions

Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States

Informations de copyright

© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

J Hum Nutr Diet. 2012 Feb;25(1):3-15
pubmed: 22118060
PLoS One. 2017 Jun 8;12(6):e0175790
pubmed: 28594820
J Alzheimers Dis. 2015;43(1):275-87
pubmed: 25079802
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Mech Ageing Dev. 2019 Mar;178:46-63
pubmed: 30650338
Psychosomatics. 2016 Mar-Apr;57(2):208-16
pubmed: 26892326
J Am Geriatr Soc. 2011 May;59(5):814-21
pubmed: 21568952
J Gerontol A Biol Sci Med Sci. 2019 Oct 26;:
pubmed: 31665233
Neuropsychology. 2016 Nov;30(8):946-960
pubmed: 27797542
Aging (Albany NY). 2016 Dec 3;8(12):3241-3254
pubmed: 27922822
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Turk J Med Sci. 2015;45(5):1040-6
pubmed: 26738345
Psychol Methods. 2002 Jun;7(2):147-77
pubmed: 12090408
Lancet Neurol. 2012 Aug;11(8):669-78
pubmed: 22749065
Lancet Neurol. 2012 Nov;11(11):1006-12
pubmed: 23079557
J Alzheimers Dis. 2019;67(1):67-79
pubmed: 30507569
J Gerontol. 1982 May;37(3):323-9
pubmed: 7069156
J Neuropathol Exp Neurol. 2019 Mar 1;78(3):219-228
pubmed: 30715383
Neurology. 1989 Sep;39(9):1159-65
pubmed: 2771064
Mol Psychiatry. 2017 Feb;22(2):287-295
pubmed: 27021820
Phys Chem Chem Phys. 2015 Apr 7;17(13):8338-48
pubmed: 25406896
J Alzheimers Dis. 2018;61(4):1509-1516
pubmed: 29376867
J Gerontol A Biol Sci Med Sci. 2020 Mar 9;75(4):779-783
pubmed: 31112230
Neurobiol Aging. 2010 Aug;31(8):1340-54
pubmed: 20570401
Annu Rev Psychol. 2009;60:549-76
pubmed: 18652544
PLoS One. 2019 May 31;14(5):e0216413
pubmed: 31150419
Age Ageing. 1997 Sep;26(5):393-400
pubmed: 9351484
Psychol Bull. 1990 Mar;107(2):238-46
pubmed: 2320703
Alzheimers Dement. 2015 May;11(5):549-60
pubmed: 25282381
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2
pubmed: 9330978
Am J Geriatr Psychiatry. 1995 Winter;3(1):60-67
pubmed: 28530960
Dement Geriatr Cogn Disord. 2010;30(3):189-97
pubmed: 20798539
J Clin Endocrinol Metab. 2011 Aug;96(8):2464-74
pubmed: 21677041
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Cochrane Database Syst Rev. 2017 Mar 22;3:CD010803
pubmed: 28328043
Front Endocrinol (Lausanne). 2019 Mar 14;10:142
pubmed: 30923512
Ann Neurol. 2009 Apr;65(4):403-13
pubmed: 19296504
Alzheimers Dement. 2013 May;9(3):332-7
pubmed: 23110865
Curr Gerontol Geriatr Res. 2010;:
pubmed: 20706534
J Alzheimers Dis. 2015;49(2):531-45
pubmed: 26444761
J Alzheimers Dis. 2015;46(4):947-61
pubmed: 25881911
Alzheimers Dement (Amst). 2016 Feb 26;3:35-42
pubmed: 27239547
Diabetologia. 2018 Oct;61(10):2215-2224
pubmed: 30046852
PLoS One. 2017 Mar 14;12(3):e0172268
pubmed: 28291794
Heart. 2015 Apr;101(8):616-22
pubmed: 25480883
Br J Psychiatry. 1982 Jun;140:566-72
pubmed: 7104545
J Alzheimers Dis. 2009;18(2):413-7
pubmed: 19661632
J Magn Reson Imaging. 2008 Apr;27(4):685-91
pubmed: 18302232
Alzheimers Dement. 2015 Jul;11(7):730-3
pubmed: 26194308
Mol Med. 2011;17(7-8):599-606
pubmed: 21738953
PLoS One. 2012;7(9):e44260
pubmed: 23028511
Scand J Clin Lab Invest. 1997 Dec;57(8):695-702
pubmed: 9458492
Dement Geriatr Cogn Disord. 1998 May-Jun;9(3):126-9
pubmed: 9621998
Ann Neurol. 2013 Oct;74(4):517-26
pubmed: 23794448
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1129-1138
pubmed: 29651545
Acta Neuropathol. 2014 Dec;128(6):755-66
pubmed: 25348064
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4299-303
pubmed: 7753801
Front Aging Neurosci. 2015 Sep 08;7:172
pubmed: 26441635
Clin Chem Lab Med. 2002 Nov;40(11):1123-31
pubmed: 12521230
Curr Alzheimer Res. 2014;11(10):928-40
pubmed: 25387341
J Alzheimers Dis. 2012;30(3):639-49
pubmed: 22451315
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Lancet Neurol. 2014 Sep;13(9):913-23
pubmed: 25142458
Neuropsychology. 2015 May;29(3):344-52
pubmed: 25151112
Alzheimers Dement. 2010 May;6(3):221-9
pubmed: 20451870
Front Aging Neurosci. 2018 Dec 17;10:414
pubmed: 30618720
J Neuropsychiatry Clin Neurosci. 2014 Summer;26(3):214-20
pubmed: 24618911
Biochem Biophys Res Commun. 1995 Jun 15;211(2):349-53
pubmed: 7794242
Front Behav Neurosci. 2014 Oct 24;8:369
pubmed: 25386125
Alzheimers Dement. 2010 May;6(3):265-73
pubmed: 20451875
J Neuropsychiatry Clin Neurosci. 2007 Summer;19(3):249-65
pubmed: 17827410
J Alzheimers Dis. 2012;29(1):151-7
pubmed: 22232009
Neurology. 2016 Apr 12;86(15):1377-1385
pubmed: 26968515
J Am Geriatr Soc. 1989 Sep;37(9):856-60
pubmed: 2760379
Ageing Res Rev. 2018 Nov;47:214-277
pubmed: 30071357

Auteurs

Donald R Royall (DR)

Department of Psychiatry, The University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.
Department of Medicine, The University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.
Department of Family and Community Medicine, The University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.
The Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, The University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.

Raymond F Palmer (RF)

Department of Family and Community Medicine, The University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.

Classifications MeSH